ATAI
Price
$1.98
Change
+$0.01 (+0.51%)
Updated
Apr 30, 6:59 PM EST
13 days until earnings call
NTLA
Price
$21.40
Change
-$0.58 (-2.64%)
Updated
Apr 30, 6:59 PM EST
One day until earnings call
Ad is loading...

ATAI vs NTLA ᐉ Comparison: Which is Better to Invest?

Header iconATAI vs NTLA Comparison
Open Charts ATAI vs NTLABanner chart's image
ATAI Life Sciences
Price$1.98
Change+$0.01 (+0.51%)
Volume$498.29K
CapitalizationN/A
Intellia Therapeutics
Price$21.40
Change-$0.58 (-2.64%)
Volume$655.18K
CapitalizationN/A
View a ticker or compare two or three
ATAI vs NTLA Comparison Chart

Loading...

ATAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATAI vs. NTLA commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and NTLA is a Hold.

COMPARISON
Comparison
May 01, 2024
Stock price -- (ATAI: $1.97 vs. NTLA: $21.98)
Brand notoriety: ATAI and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 63% vs. NTLA: 93%
Market capitalization -- ATAI: $331.48M vs. NTLA: $2.06B
ATAI [@Biotechnology] is valued at $331.48M. NTLA’s [@Biotechnology] market capitalization is $2.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 2 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 2 bullish, 7 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а +5.35% price change this week, while NTLA (@Biotechnology) price change was +0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.49%. For the same industry, the average monthly price growth was -6.90%, and the average quarterly price growth was +1243.59%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 12, 2024.

NTLA is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATAI with price predictions.
OPEN
A.I.dvisor published
a Summary for NTLA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NTLA($2.06B) has a higher market cap than ATAI($330M). ATAI YTD gains are higher at: 39.716 vs. NTLA (-27.911).
ATAINTLAATAI / NTLA
Capitalization330M2.06B16%
EBITDAN/AN/A-
Gain YTD39.716-27.911-142%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ATAI vs NTLA: Fundamental Ratings
ATAI
NTLA
OUTLOOK RATING
1..100
8256
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
9095
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
4282
P/E GROWTH RATING
1..100
20100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (44) in the Biotechnology industry is somewhat better than the same rating for ATAI (84) in the Miscellaneous Commercial Services industry. This means that NTLA’s stock grew somewhat faster than ATAI’s over the last 12 months.

ATAI's Profit vs Risk Rating (90) in the Miscellaneous Commercial Services industry is in the same range as NTLA (95) in the Biotechnology industry. This means that ATAI’s stock grew similarly to NTLA’s over the last 12 months.

ATAI's SMR Rating (94) in the Miscellaneous Commercial Services industry is in the same range as NTLA (96) in the Biotechnology industry. This means that ATAI’s stock grew similarly to NTLA’s over the last 12 months.

ATAI's Price Growth Rating (42) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for NTLA (82) in the Biotechnology industry. This means that ATAI’s stock grew somewhat faster than NTLA’s over the last 12 months.

ATAI's P/E Growth Rating (20) in the Miscellaneous Commercial Services industry is significantly better than the same rating for NTLA (100) in the Biotechnology industry. This means that ATAI’s stock grew significantly faster than NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAINTLA
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ATAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXISX12.500.08
+0.64%
Empower S&P SmallCap 600® Index Inv
VMIDX25.800.15
+0.58%
VALIC Company I Mid Cap Index
TIQRX36.570.12
+0.33%
TIAA-CREF Equity Index R
GCPCX17.660.05
+0.28%
Gateway Equity Call Premium C
AQLGX16.46-0.05
-0.30%
Alta Quality Growth Institutional

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with ALLO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+2.07%
ALLO - ATAI
48%
Loosely correlated
-1.73%
MNMD - ATAI
45%
Loosely correlated
+5.99%
COUR - ATAI
45%
Loosely correlated
-0.67%
VCYT - ATAI
45%
Loosely correlated
+5.33%
NTLA - ATAI
44%
Loosely correlated
+5.88%
More